D-Wave Quantum's $100M Windfall and 2,000% Bookings Surge Set Stage for First Investor Day

D-Wave Quantum jumps to $29.52 after $100M CHIPS Act commitment; Q1 bookings surge to $33.4M despite revenue dip; investor day set for June 1.

D-Wave Quantum closed the final week of May with a 7.4% pop to $29.52, pushing the stock to €25.33 — nearly double its 50-day moving average of €16.91. The surge came as the company’s management took the stage at the TD Cowen conference in New York, but the real catalyst was a $100 million funding commitment from Washington that lit a fire under the entire quantum sector.

The US Department of Commerce, under the CHIPS and Science Act, pledged over $2 billion in grants for quantum computing firms. D-Wave signed a non-binding letter of intent for $100 million, earmarked for superconducting annealing and gate-model systems. In a strategic pivot, the government will take minority stakes in recipients — a first for US tech funding. The market responded with conviction: 54 million shares traded hands, 69% above the daily average, pushing D-Wave’s market cap past $10 billion.

Q1: Revenue Stumbles, but a Backlog Boom

The company’s first-quarter results, released May 12, tell a tale of two curves. Revenue plunged 81% to $2.9 million, a steep drop from $15 million a year ago, because the prior-year quarter included a large system sale that did not repeat. Yet bookings exploded from $1.6 million to $33.4 million — a nearly 2,000% leap. The standout was a $20 million system sale to Florida Atlantic University and a $10 million QCaaS contract with a Fortune 100 company.

The backlog of unsatisfied performance obligations reached $42.4 million, up from $6.4 million a year earlier. Of that, 54% is expected to convert to revenue within twelve months and 71% within two years. The net loss widened to $18.4 million from $5.4 million, driven by higher operating expenses and lower gross margins. But the balance sheet remains solid: D-Wave holds $588.4 million in cash and securities, 93% more than last year.

Analyst Optimism Tempered by Measured Targets

Wall Street is leaning bullish. Fourteen of seventeen analysts rate the stock a Buy, two say Hold, and one recommends Sell. The average 12-month price target sits near $34, roughly 17% above Thursday’s close. Mizuho trimmed its target to $29 but kept an Outperform rating, while Rosenblatt Securities is far more aggressive at $43. The stock’s RSI of 49.4 leaves room for movement in either direction — neither overbought nor oversold.

First Investor Day: The Big Test

All roads lead to Monday, June 1, when D-Wave hosts its inaugural investor day at the New York Stock Exchange under the banner “The D-Wave Difference.” Management will detail its dual-platform strategy: covering both annealing and gate-model quantum computing, alongside the integration of Quantum Circuits, the global rollout of annealing systems, and the role of quantum in energy-efficient AI.

The event runs from 1:00 to 5:00 p.m. local time and is expected to provide granular insight into the product roadmap and commercial momentum. For investors, the central question is whether D-Wave can convert its record booking pipeline into sustainable revenue growth. With a market cap around $10 billion, the stock is pricing in not just hype but real commercial traction.

The stock has more than doubled from its 52-week low of €11.32 in late March, but still sits 34% below its high of €38.48. Monday’s presentation will determine whether that gap narrows or widens.